It has been reported that abnormalities of functional brain asymmetry was detected in patients with major depressive disorder (MDD). However, little is known about their clinical implication. The aim of this study was to examine the differences in asymmetry indexes (AIs) of hippocampus between MDD patients and healthy controls (HCs) and their relationship with cognitive functions. Forty-one patients with first-episode drug-naïve MDD and 41 age-sex-matched HCs were recruited. All participants examined with 1.5T high-resolution magnetic resonance imaging. Two different methods for image analyses included manual method and FreeSurfer.
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Hemispheric differences in the relationship of serotonin transporter availability and hippocampal volumes in the human brain 
Abstract
Hippocampus and serotonin transporter (SERT) comes from two totally distinct systems but share a similar function, regulation of mood. Reduction of hippocampal volumes has been consistently reported in patient with major depressive disorder (MDD). Meanwhile, alteration of SERT, which terminates the serotonin action, has been implicated in the pathophysiology of MDD. However, the study of the functional and structural relationship between hippocampus and SERT was still limited. The aim of this study was to examine their relationship in the human brain. Six-four healthy subjects were recruited. All participants examined with 1.5T high-resolution magnetic resonance imaging. Image was analyzed by two different methods: manual and FreeSurfer.
Manual method was applied to analyze the longitudinal axis of hippocampal volumes, which included head, body and tail body. FreeSurfer was used to analyze the volumes of hippocampal subfields.
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I-ADAM with single-photon emission computed tomography was applied for SERT imaging. Regions of interest included the midbrain, thalamus, caudate and putamen. Linear regression analysis was applied for the association of SERT and hippocampus. When took into account of age, sex and educational levels, SERT in the midbrain was associated with left total hippocampal volume (R2=0.15, adjusted R2=0.10, F=2.68, p=0.04), mainly contributed by body (β=0.33, t=2.66, p=0.01) and tail (β=0.31, t=2.55, p=0.013), but not right total hippocampal volume. In contrast, SERT in the thalamus was significantly associated with right total hippocampal volume (R 2 =0.15, adjusted R 2 =0.09, F=2.57, p=0.04), mainly contributed by head (β=0.32, t=2.5, p=0.02) but not left total hippocampus. There was no significant association between SERT and subfields of hippocampus. In conclusion, our results suggest that the association of serotonergic system and hippocampus is hemispheric different. A further study to test this idea in MDD is warrant. Key words: hippocampus, serotonin transporter, SPECT
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Hybrid PET/MR imaging of serotonin transporter occupancy and brain activation to elucidate the mechanism of action of selective serotonin reuptake inhibitors 
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Abstract Objective: While selective serotonin reuptake inhibitors (SSRIs) constitute first line therapy of depression and anxiety disorders, their mechanism of action remains to be elucidated. Hybrid PET/ MR systems allow us to simultaneously probe the engagement of molecular targets and concomitant changes in brain activity following the application of psychopharmaceuticals. This study was aimed to establish imaging methods to be applied on clinical samples in the future. Methods: 7 subjects underwent two measurements at the Biograph mMR scanner. [ 11 C]DASB was applied as bolus plus constant infusion. After 60 minutes, double-blind infusion of 7.5mg citalopram or saline was performed and scanning was continued for 60 minutes, such that equilibrium was attained. An event-related emotion identification paradigm was performed before and after drug challenge. Serotonin transporter occupancy was calculated from binding potentials obtained using metabolite-corrected plasma activity at equilibrium and non-specific binding from cerebellum. Results: Average serotonin transporter occupancy was 62% in the regions investigated (thalamus: 63 ± 16%, amygdala: 61%±17%, midbrain: 54%±17%, putamen: 64 ± 13%, nucleus caudatus: Abstracts | 61 67%±13%). Functional MRI revealed decreased activation in the right inferior frontal (rIFC, p FWE-cluster =0.02) and left middle temporal gyri (lMTG, p FWE-cluster =0.03) to negative faces following citalopram infusion (for p=0.001 uncorrected on peak level).
Conclusions:
The newly implemented methods yielded serotonin transporter occupancy values in agreement with published data obtained using well validated procedures [1] . FMRI results are at odds with increased activity during an emotional paradigm in the lMTG following 10 days of SSRI treatment observed by our group [2] . Further, meta-analysis revealed lower activation to negative stimuli in the rIFC of depressed patients [3] . These preliminary results indicate that acute challenge with a subtherapeutic SSRI dose elicits brain activation changes distinct to those seen with prolonged treatment. It will be interesting to see what insights will arise from direct integration of molecular and functional imaging data in clinical populations.
